CIK 0000890821 · Non-accelerated filer<br>Smaller reporting company
Enveric Biosciences, Inc.
Sign in to watch- Ticker
- ENVB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954484725
- Phone
- (617) 444-8400
- Business address
- 245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE, MA, 02142
- Former names
- AMERI Holdings, Inc., SPATIALIZER AUDIO LABORATORIES INC
- 8-K Event Material agreement · New debt or obligation
- 4 Open-market buy Director bought 1,360 shares at $6.51 ($8,854)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 28 shares at $6.51 ($182)
- 8-K Event Unregistered share sale · Other events
- 8-K Event Executive or director change
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 4 Open-market buy Director bought 1,084 shares at $6.51 ($7,057)
- 4 Open-market buy Director bought 804 shares at $6.51 ($5,234)
- 4 Open-market buy Director bought 100 shares at $6.51 ($651)
- DEF 14A Proxy Proxy Statement
- SC 13D/A Stake Beneficial Ownership Report
- 4 Option exercise Director acquired 1,111,111 shares (option exercise)
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Open-market buy Director bought 146 shares at an average $6.51 ($950)
- 8-K Event Material agreement · Unregistered share sale
Page 37 of 53 · 1,057 filings